Study Summary: This study looks at a special surgery called *hepato-celiac lymphadenectomy* for treating ovarian cancer. This surgery removes certain lymph nodes near the liver and stomach. It aims to check if this surgery is safe and effective for women with advanced ovarian cancer or for those whose cancer has come back after being treated with platinum-based chemotherapy.
*Ovarian cancer* is a disease where cancer cells grow in or near a woman's ovaries. *Platinum-sensitive* means the cancer responds to drugs with a metal called platinum, and if it returns, it can still be treated with these drugs.
The study includes women aged 18 to 75 years who have advanced ovarian cancer or cancer that returned after treatment. It requires a pre-evaluation to ensure that the cancer can be fully removed by surgery. Participants must be fit for surgery and chemotherapy, and need to have good bone marrow, liver, and kidney function.
- Study involves surgery and possibly chemotherapy.
- Participants need to be available for follow-ups after treatment.
- Eligibility depends on health status and previous treatment responses.
How understandable was the trial content above?
Hard to understand
Easy to understand